Article: First Genetic Trust & Galileo Genomics Announce Strategic Collaboration to Provide Innovative Pharmacogenomics Research Products & Services.

MONTREAL -- MONTREAL, June 10 /PRNewswire/ -- First Genetic Trust (FGT) and Galileo Genomics (GG) have announced a collaboration to provide innovative pharmacogenomics research capabilities to the pharmaceutical and biotechnology industry. The collaboration will create an unprecedented research resource of large-scale clinical networks from Quebec and the US. The collaboration will provide innovative and targeted pharmacogenomics services across a wide range of key therapeutic areas, including inflammation and immunological diseases, cardiovascular and metabolic diseases, and CNS/psychiatric disorders.

Galileo Genomics will provide derived data from its ...






Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!